OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP. Share Price

Certificat

DE000GG5JSZ4

Real-time BOERSE MUENCHEN 15:27:32 20/06/2024 BST
1.33 EUR +23.15% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - STRYKER CORP.
Current month-46.00%
1 month-58.30%
Date Price Change
20/06/24 1.33 +23.15%
19/06/24 1.08 -16.28%
18/06/24 1.29 -15.69%
17/06/24 1.53 -10.00%
14/06/24 1.7 +1.19%

Real-time BOERSE MUENCHEN

Last update June 20, 2024 at 03:27 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GG5JSZ
ISINDE000GG5JSZ4
Date issued 20/03/2024
Strike 360.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.34
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.46
Lowest since issue 0.001
Spread 0.03
Spread %1.85%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus